Metraipolis › archive › dc_90fb6e2fdc29

Advances in Mesoporous Silica and Hybrid Nanoparticles for Drug Delivery: Synthesis, Functionalization, and Biomedical Applications — Europe PMC PMID:41471116

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41471116
DOI
10.3390/pharmaceutics17121602
License (as archived)
solo-consultazione
Archived
2026-11-07T17:05:00.035Z
SHA-256 of the archived text
8db8c2b168041483440cea328cf0fd2c223c2d027efb7c38fe39af244af9dd25
Stable URL of this page
https://metraipolis.com/documento/dc_90fb6e2fdc29

How to cite

Advances in Mesoporous Silica and Hybrid Nanoparticles for Drug Delivery: Synthesis, Functionalization, and Biomedical Applications — Europe PMC PMID:41471116 — Europe PMC (en), https://europepmc.org/article/MED/41471116 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_90fb6e2fdc29 (Metraipolis archive dc_90fb6e2fdc29, sha256 8db8c2b168041483440cea328cf0fd2c223c2d027efb7c38fe39af244af9dd25)
BibTeX
@misc{dc90fb6e2fdc29,
  title = {Advances in Mesoporous Silica and Hybrid Nanoparticles for Drug Delivery: Synthesis, Functionalization, and Biomedical Applications — Europe PMC PMID:41471116},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41471116},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_90fb6e2fdc29; sha256 8db8c2b168041483440cea328cf0fd2c223c2d027efb7c38fe39af244af9dd25},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471116. Agents can read the archived copy with the MCP tool read_document.